All In MedTech

Device Trial Radar · NCT01520337

Polyp Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy

Last checked: Nov 19, 2026Latest source record: Feb 11, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

170

Actual

Start

Jan 2012

Primary completion

Mar 2013

Study completion Oct 2013

Sponsor

Lead sponsor
Cosmo Technologies LtdNot on our public-company list
Sponsor type
Industry
First posted
Jan 27, 2012

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Polyp detection rate in colonoscopy following oral administration of MMX methylene blue tablets

Conditions

  • Polyp and Adenoma Detection During Colonoscopy

Interventions

  • oral tablet dye for detection of polyps during colonoscopyDevice

    oral tablet dye for improved detection of

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Polyp and adenoma detection rateTime frame: 1 day

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.